DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Patrikidou A, Chabaud S, Ray-Coquard I et al.
Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trial.
Ann Oncol 2013;
24: 1087-1093
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.